Procept Biorobotics Corp Stock Fundamentals
| PRCT Stock | USD 95.59 1.70 1.75% |
Procept Biorobotics Corp fundamentals help investors to digest information that contributes to Procept Biorobotics' financial success or failures. It also enables traders to predict the movement of Procept Stock. The fundamental analysis module provides a way to measure Procept Biorobotics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Procept Biorobotics stock.
At this time, Procept Biorobotics' Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 5.8 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 130.9 M in 2024. Procept | Select Account or Indicator |
Procept Biorobotics Corp Company Return On Equity Analysis
Procept Biorobotics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Procept Biorobotics Return On Equity | -0.37 |
Most of Procept Biorobotics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procept Biorobotics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Procept Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Procept Biorobotics Corp has a Return On Equity of -0.3702. This is 98.46% lower than that of the Health Care Equipment & Supplies sector and 95.76% lower than that of the Health Care industry. The return on equity for all United States stocks is 19.42% higher than that of the company.
Procept Biorobotics Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Procept Biorobotics's current stock value. Our valuation model uses many indicators to compare Procept Biorobotics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Procept Biorobotics competition to find correlations between indicators driving Procept Biorobotics's intrinsic value. More Info.Procept Biorobotics Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Procept Biorobotics' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Procept Biorobotics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Procept Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procept Biorobotics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procept Biorobotics could also be used in its relative valuation, which is a method of valuing Procept Biorobotics by comparing valuation metrics of similar companies.Procept Biorobotics is currently under evaluation in return on equity category among its peers.
Procept Biorobotics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Procept Biorobotics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Procept Biorobotics' managers, analysts, and investors.Environmental | Governance | Social |
Procept Fundamentals
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 5.15 B | ||||
| Shares Outstanding | 54.11 M | ||||
| Shares Owned By Insiders | 4.60 % | ||||
| Shares Owned By Institutions | 86.33 % | ||||
| Number Of Shares Shorted | 6.37 M | ||||
| Price To Book | 21.82 X | ||||
| Price To Sales | 26.34 X | ||||
| Revenue | 136.19 M | ||||
| Gross Profit | 37.09 M | ||||
| EBITDA | (98.09 M) | ||||
| Net Income | (105.9 M) | ||||
| Cash And Equivalents | 269.81 M | ||||
| Cash Per Share | 6.05 X | ||||
| Total Debt | 79.2 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 16.01 X | ||||
| Book Value Per Share | 4.63 X | ||||
| Cash Flow From Operations | (108 M) | ||||
| Short Ratio | 5.40 X | ||||
| Earnings Per Share | (1.95) X | ||||
| Price To Earnings To Growth | (0.47) X | ||||
| Target Price | 100.83 | ||||
| Number Of Employees | 626 | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 5.26 B | ||||
| Total Asset | 404.72 M | ||||
| Retained Earnings | (454.57 M) | ||||
| Working Capital | 304.64 M | ||||
| Net Asset | 404.72 M |
About Procept Biorobotics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procept Biorobotics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procept Biorobotics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procept Biorobotics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 5.7 M | 5.9 M | |
| Total Revenue | 136.2 M | 143 M | |
| Cost Of Revenue | 65.1 M | 68.4 M | |
| Stock Based Compensation To Revenue | 0.14 | 0.22 | |
| Research And Ddevelopement To Revenue | 0.36 | 0.34 | |
| Capex To Revenue | 0.19 | 0.33 | |
| Revenue Per Share | 2.88 | 3.03 | |
| Ebit Per Revenue | (0.80) | (0.84) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.